Switch theme
Sign up to access all valuation multiples
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. It also offers services such as training in connection with product sales. Geographically, it derives a majority of revenue from Western Europe and also has a presence in North America; and the Rest of the World.
1957
7.2K+
LTM Revenue $1.2B
LTM EBITDA $211M
$980M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Arjo has a last 12-month revenue (LTM) of $1.2B and a last 12-month EBITDA of $211M.
In the most recent fiscal year, Arjo achieved revenue of $1.2B and an EBITDA of $210M.
Arjo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Arjo valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Profit | $455M | XXX | $513M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 43% | XXX | XXX | XXX |
| EBITDA | $211M | XXX | $210M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBIT | $98.6M | XXX | $107M | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $51.9M | XXX | $52.1M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $339M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Arjo's stock price is SEK 33 (or $3).
Arjo has current market cap of SEK 9.0B (or $936M), and EV of SEK 9.4B (or $980M).
See Arjo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $980M | $936M | XXX | XXX | XXX | XXX | $0.21 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Arjo has market cap of $936M and EV of $980M.
Arjo's trades at 0.8x EV/Revenue multiple, and 4.7x EV/EBITDA.
Equity research analysts estimate Arjo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Arjo has a P/E ratio of 18.0x.
See valuation multiples for Arjo and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $936M | XXX | $936M | XXX | XXX | XXX |
| EV (current) | $980M | XXX | $980M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 4.6x | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBIT | 9.9x | XXX | 9.2x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.0x | XXX | 18.0x | XXX | XXX | XXX |
| EV/FCF | 14.0x | XXX | 11.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialArjo's last 12 month revenue growth is 1%
Arjo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Arjo's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Arjo's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Arjo and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | 19% | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Arjo acquired XXX companies to date.
Last acquisition by Arjo was XXXXXXXX, XXXXX XXXXX XXXXXX . Arjo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Arjo founded? | Arjo was founded in 1957. |
| Where is Arjo headquartered? | Arjo is headquartered in Sweden. |
| How many employees does Arjo have? | As of today, Arjo has 7.2K+ employees. |
| Who is the CEO of Arjo? | Arjo's CEO is Mr. Niclas Sjosward. |
| Is Arjo publicy listed? | Yes, Arjo is a public company listed on STO. |
| What is the stock symbol of Arjo? | Arjo trades under ARJO B ticker. |
| When did Arjo go public? | Arjo went public in 2017. |
| Who are competitors of Arjo? | Similar companies to Arjo include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Arjo? | Arjo's current market cap is $936M |
| What is the current revenue of Arjo? | Arjo's last 12 months revenue is $1.2B. |
| What is the current revenue growth of Arjo? | Arjo revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Arjo? | Current revenue multiple of Arjo is 0.8x. |
| Is Arjo profitable? | Yes, Arjo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Arjo? | Arjo's last 12 months EBITDA is $211M. |
| What is Arjo's EBITDA margin? | Arjo's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Arjo? | Current EBITDA multiple of Arjo is 4.6x. |
| What is the current FCF of Arjo? | Arjo's last 12 months FCF is $70.1M. |
| What is Arjo's FCF margin? | Arjo's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Arjo? | Current FCF multiple of Arjo is 14.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
